These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36889712)

  • 1. Long-term Observation of a Japanese Patient with a Multiple-system Neurodegenerative Disorder with a Uniallelic de novo Missense Variant in KIF1A.
    Nakamura K; Yoshinaga T; Kodaira M; Kise E; Kosho T; Sekijima Y
    Intern Med; 2023 Oct; 62(20):3047-3051. PubMed ID: 36889712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity.
    Hama Y; Date H; Fujimoto A; Matsui A; Ishiura H; Mitsui J; Yamamoto T; Tsuji S; Mizusawa H; Takahashi Y
    Cerebellum; 2023 Dec; 22(6):1308-1311. PubMed ID: 36227410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF1A mutation in a patient with progressive neurodegeneration.
    Okamoto N; Miya F; Tsunoda T; Yanagihara K; Kato M; Saitoh S; Yamasaki M; Kanemura Y; Kosaki K
    J Hum Genet; 2014 Nov; 59(11):639-41. PubMed ID: 25253658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors.
    Anazawa Y; Kita T; Iguchi R; Hayashi K; Niwa S
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2113795119. PubMed ID: 35917346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous
    Nicita F; Ginevrino M; Travaglini L; D'Arrigo S; Zorzi G; Borgatti R; Terrone G; Catteruccia M; Vasco G; Brankovic V; Siliquini S; Romano S; Veredice C; Pedemonte M; Armando M; Lettori D; Stregapede F; Bosco L; Sferra A; Tessarollo V; Romaniello R; Ristori G; Bertini E; Valente EM; Zanni G
    J Med Genet; 2021 Jul; 58(7):475-483. PubMed ID: 32737135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel De Novo Missense Mutation in
    Bernard E; Cluse F; Bohic A; Hermier M; Raoul C; Leblanc P; Guissart C
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance.
    Ohba C; Haginoya K; Osaka H; Kubota K; Ishiyama A; Hiraide T; Komaki H; Sasaki M; Miyatake S; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    J Hum Genet; 2015 Dec; 60(12):739-42. PubMed ID: 26354034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A).
    Kaur S; Van Bergen NJ; Verhey KJ; Nowell CJ; Budaitis B; Yue Y; Ellaway C; Brunetti-Pierri N; Cappuccio G; Bruno I; Boyle L; Nigro V; Torella A; Roscioli T; Cowley MJ; Massey S; Sonawane R; Burton MD; Schonewolf-Greulich B; Tümer Z; Chung WK; Gold WA; Christodoulou J
    Hum Mutat; 2020 Oct; 41(10):1761-1774. PubMed ID: 32652677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up until early adulthood in autosomal dominant, complex SPG30 with a novel KIF1A variant: a case report.
    Spagnoli C; Rizzi S; Salerno GG; Frattini D; Fusco C
    Ital J Pediatr; 2019 Dec; 45(1):155. PubMed ID: 31796088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [KIF1A gene-associated neurological disease: the correlation between genotype and phenotype].
    Ortiz-Ortigosa A; Calvo-Medina R; Ruiz-García C; Vera-Medialdea R; Ramos-Fernández JM
    Rev Neurol; 2023 Sep; 77(6):141-145. PubMed ID: 37668235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder.
    Sudnawa KK; Li W; Calamia S; Kanner CH; Bain JM; Abdelhakim AH; Geltzeiler A; Mebane CM; Provenzano FA; Sands TT; Fee RJ; Montes J; Shen Y; Chung WK
    Genet Med; 2024 Aug; 26(8):101169. PubMed ID: 38785164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome.
    Aguilera C; Hümmer S; Masanas M; Gabau E; Guitart M; Jeyaprakash AA; Segura MF; Santamaria A; Ruiz A
    Front Neurosci; 2021; 15():618098. PubMed ID: 34121983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.
    Lee JR; Srour M; Kim D; Hamdan FF; Lim SH; Brunel-Guitton C; Décarie JC; Rossignol E; Mitchell GA; Schreiber A; Moran R; Van Haren K; Richardson R; Nicolai J; Oberndorff KM; Wagner JD; Boycott KM; Rahikkala E; Junna N; Tyynismaa H; Cuppen I; Verbeek NE; Stumpel CT; Willemsen MA; de Munnik SA; Rouleau GA; Kim E; Kamsteeg EJ; Kleefstra T; Michaud JL
    Hum Mutat; 2015 Jan; 36(1):69-78. PubMed ID: 25265257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder.
    Tomaselli PJ; Rossor AM; Horga A; Laura M; Blake JC; Houlden H; Reilly MM
    J Peripher Nerv Syst; 2017 Dec; 22(4):460-463. PubMed ID: 28834584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome.
    Langlois S; Tarailo-Graovac M; Sayson B; Drögemöller B; Swenerton A; Ross CJ; Wasserman WW; van Karnebeek CD
    Eur J Hum Genet; 2016 Jun; 24(6):949-53. PubMed ID: 26486474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhagic shock and encephalopathy syndrome in a patient with a de novo heterozygous variant in KIF1A.
    Isobe K; Ieda D; Miya F; Miyachi R; Otsuji S; Asai M; Tsunoda T; Kosaki K; Hattori A; Saitoh S; Mizuno M
    Brain Dev; 2022 Mar; 44(3):249-253. PubMed ID: 34916088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy.
    Esmaeeli Nieh S; Madou MR; Sirajuddin M; Fregeau B; McKnight D; Lexa K; Strober J; Spaeth C; Hallinan BE; Smaoui N; Pappas JG; Burrow TA; McDonald MT; Latibashvili M; Leshinsky-Silver E; Lev D; Blumkin L; Vale RD; Barkovich AJ; Sherr EH
    Ann Clin Transl Neurol; 2015 Jun; 2(6):623-35. PubMed ID: 26125038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
    Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
    Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pathogenic variant in the 3' end of the AGTPBP1 gene gives rise to neurodegeneration without cerebellar atrophy: an expansion of the disease phenotype?
    Türay S; Eröz R; Başak AN
    Neurogenetics; 2021 May; 22(2):127-132. PubMed ID: 33909173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.